A Case of Superior Mesenteric Artery Occlusion Caused by Portal Vein Stenting Authors: Kenji Takata, Toyohiko Sakai, Midori Ueda, Kiyotaka Takeuchi, Hideaki Komiya, Daisuke Yoshikawa, Satomi Kanai, Tasuku Wakabayashi, Ayaki Kitano, Mariko Toyooka, Tetsuya Tsujikawa Published: 2025 ABSTRACT AbstractPortal vein stenting treats stenosis or thrombosis of the portal venous system with relatively high technical and clinical success rates. However, complications have been reported. We present a case of a 58-year-old woman with a history of pancreatic head cancer surgery who developed superior mesenteric vein occlusion owing to recurrent mesenteric lesions. Portal vein stenting was performed; however, it resulted in superior mesenteric artery occlusion, which caused extensive intestinal ischemia. Gas from the intestinal necrosis migrated into the superior mesenteric artery and superior mesenteric vein, and thrombotic occlusion of the portal vein stent was observed. This complication, which is characterized by superior mesenteric artery occlusion induced by portal vein stenting, is unique. Furthermore, this case highlights the need for a thorough preoperative evaluation and careful consideration to avoid such a rare but severe complication.Keywords: portal vein stenting, SMV occlusion, SMA occlusion complications Introduction Portal vein stent placement is a treatment for prehepatic portal hypertension caused by extrahepatic portal vein stenosis or obstruction [1]. Specifically, the purpose of placing a portal vein stent is to reduce portal pressure and alleviate symptoms of portal hypertension, maintain intrahepatic blood flow, and prevent deterioration of liver function, and prevent malignant tumors from spreading into the portal vein. The technical and clinical success rates of portal vein stent placement have been previously reported nearly 80%, with a certain incidence of complications [2, 3]. Reported complications include bleeding associated with the percutaneous transhepatic route (intrahepatic or intraperitoneal bleeding), hepatic artery injury, portal vein thrombosis, liver abscess, stent migration, and stent occlusion [3]. We encountered a case where a portal vein stent compressed the adjacent SMA, leading to occlusion. No similar cases have been reported, making it an extremely rare condition. In addition, the SMA occlusion caused intestinal ischemia and a rare finding of gas entering the arterial system was observed. Portal vein stent placement has become more widely performed; hence, raising awareness of such complications and providing valuable insights for determining treatment strategies is important. Case Report The patient was a 58-year-old woman who had undergone subtotal stomach-preserving pancreatoduodenectomy for pancreatic head cancer 9 years earlier. During surgery, the nerve plexus around the SMA was dissected with resection of the first jejunal and middle colic arteries. Postoperative chemotherapy was administered; however, a recurrent lesion appeared in the mesentery 2 years ago. Chemotherapy was continued; however, the recurrent lesion enlarged, with subsequent invasion and stenosis of the SMA and SMV. Radiotherapy (48 Gy/20 Fr) was also administered for the recurrent lesion. The patient was admitted with an obstruction of the elevated jejunum owing to a recurrent lesion, resulting in retrograde cholangitis and septic shock. Contrast-enhanced CT revealed further growth of the recurrent lesion with progression of SMA stenosis and complete SMV occlusion (Figure 1 and 2). Portal hypertension, including massive ascites and marked bowel edema, were observed as a result of SMV occlusion. To prevent gastrointestinal bleeding and deterioration of the patient's overall condition owing to the progression of portal hypertension, we decided to proceed with portal vein stent placement. On admission, blood tests showed a decreased platelet count of 88,000/μL, but no apparent abnormalities in blood coagulation function were observed. Axial and coronal contrast-enhanced CT images at the time of admission in a case of SMV obstruction owing to recurrence of pancreatic head cancer after surgery. (a, c) SMV is severely narrowed or obstructed by the recurrent tumor. (b, d) SMA courses through the recurrent tumor and exhibits severe narrowing owing to tumor invasion. Extensive edematous thickening of the intestinal wall is observed, accompanied by mesenteric edema and ascites. These findings are consistent with portal hypertension secondary to SMV obstruction. (a) Shows a MIP image, and (b) shows a three-dimensional (3D) volume-rendered (VR) image from the preoperative computed tomography scan. The procedure was performed under local anesthesia. Under ultrasound guidance, the intrahepatic portal vein anterior branch was punctured and a 7Fr sheath introducer IIH (Terumo, Tokyo, Japan) was inserted. Portal venography revealed occlusion of the SMV from the proximal portion (Figure 3a). A base catheter (Seeking catheter: Hanako Medical, Saitama, Japan) was advanced to the occlusion site, and a microcatheter system (Progreat λ, Terumo, Tokyo, Japan; ASAHI Meister, ASAHI Intecc, Aichi, Japan) was employed to cross the obstruction. Intraoperative angiographic images. (a) Portal venography shows severe stenosis to occlusion at the proximal segment of the SMV. (b) Venography after recanalization of the occluded segment reveals prominent collateral circulation. (c) After balloon angioplasty of the occluded segment, an improvement in antegrade portal venous flow is observed; however, residual stenosis persists. (d) After stent placement, the stenosis is resolved, and antegrade portal venous flow is significantly improved. The collateral circulation has disappeared; however, retrograde flow of the injected contrast medium into the distal SMV is observed. Furthermore, misregistration caused by contrast medium stagnation in the peripheral branches is evident. The obstruction was successfully crossed using a microcatheter system, and the catheter was advanced into the distal jejunal vein. The microguidewire was switched to a Cruise (ASAHI Intecc, Aichi, Japan), and an attempt was made to introduce a balloon catheter (SHIDEN 6 mm/40 mm, Kaneka Medics, Tokyo, Japan); however, the balloon catheter could not pass through the obstruction. Dilation of the obstruction with the microcatheter system was complex; thus, a Seeking catheter (Hanako Medical, Saitama, Japan) and a 0.035-inch Radifocus guidewire (Terumo, Tokyo, Japan) were used to attempt to cross the obstruction again, which was successful (Figure 3b). The proximal side of the occluded segment measured 10.3 mm in diameter, while the distal side measured 8.1 mm. The obstruction was then dilated using a PowerFlex Pro 8 × 40 mm balloon catheter (Cordis, Bridgewater, NJ, USA) (Figure 3c). After dilating the occluded segment, the antegrade portal venous flow was confirmed, and a metallic stent (SMART CONTROL 8 mm/10 cm; Cordis) was deployed. Residual stenosis within the stent lumen was observed, necessitating additional post-dilation. Postprocedural angiography from the catheter placed in the portal vein system demonstrated improved antegrade portal venous flow and disappearance of collateral vessels (Figure 3d). However, the contrast medium flowed into the distal SMV, and misregistration caused by the stagnation of contrast medium in the peripheral branches was also observed. We did not recognize this finding and concluded the procedure. Postoperatively, the patient experienced persistent abdominal pain, and a contrast-enhanced CT was performed 9 hours after stent placement (Figure 4 and 5). The CT scan revealed thrombotic occlusion of the portal vein stent and occlusion of the adjacent SMA. Extensive regions of poor enhancement were observed in the small intestine, indicating ischemia caused by SMA occlusion. Pneumatosis intestinalis was also observed, raising the suspicion of bowel necrosis. Furthermore, air was observed in the distal branches of the SMA (Figure 4b). Contrast-enhanced CT performed 9 hours after stent placement. Extensive intestinal hypo-enhancement and pneumatosis intestinalis are observed owing to occlusion of the SMA and SMV (a-d). (a, d) Thrombotic occlusion of the portal vein stent is evident. Adjacent to the stent, a narrowed SMA is visible, with distal occlusion of the SMA confirmed in the coronal view. (b) A tubular gas structure parallel to the portal vein stent is observed; it is considered to be within the SMA and identified as air. (a) Shows a MIP image, and (b) shows a 3D VR image from the postoperative computed tomography scan. 3D: three-dimensional; VR: volume-rendered The patient was diagnosed with compressive SMA occlusion owing to a portal vein stent, leading to ischemic bowel necrosis. Two hours after the CT scan, the blood pressure could no longer be maintained, and the patient died. Discussion Portal vein stenting is widely used to treat portal venous stenosis or thrombosis, with several methods available [4-6]. The most common method is percutaneous transhepatic access; however, percutaneous transsplenic access and transileocolic vein access are also reported options, which are selected based on each patient's anatomical and pathological conditions [5, 6]. The percutaneous transhepatic approach can be performed under local anesthesia, resulting in minimal invasiveness. However, complications related to puncture maneuvers and potential operator radiation exposure, depending on the puncture site, are the drawbacks of this approach [4]. The transileocolic vein approach requires general anesthesia and collaboration with surgeons. During the procedure, the ileocolic vein is punctured under direct visualization to minimize puncture-related complications. Moreover, this antegrade approach simplifies access to the stenotic area and allows greater flexibility in device selection [5]. The percutaneous transsplenic approach may be selected when the percutaneous transhepatic approach or general anesthesia is challenging [6]. This method is useful for treating thrombosis or stenosis in the main portal vein; however, in cases of SMV stenosis, the sharp branching angle between the SMV and the splenic vein makes this approach unsuitable. Portal vein stenosis or occlusion due to malignant tumors is attributed to hepatocellular carcinoma, pancreatic cancer, and biliary tract cancer in 15%-24% of cases [7]. Portal vein stenting for malignant tumor-induced portal vein stenosis or obstruction achieved a technical success rate of 100% and a clinical success rate of 80% [8]. The primary patency rates of the stents were 95%, 84%, and 68% at 1, 3, and 6 months, respectively [8]. The outcomes are relatively favorable; however, three factors have been reported as causes of stent occlusion. The first is a vascular factor, where infiltration of the visceral veins (such as the splenic vein or SMV) is present. The second is a tumor-related factor, including highly invasive pancreatic cancer or the absence of anticancer treatment after stent placement. The third is decreased portal blood flow due to severe liver dysfunction [7]. Although the indications for portal vein stenting have not been clearly established, it is important to consider the presence or absence of these factors when determining the appropriateness of the procedure. Common complications include bleeding, hepatic artery injury related to the puncture, portal vein thrombosis, stent stenosis or occlusion, and infection. SMA occlusion and bowel necrosis presented in our case are rare complications. A literature review revealed that no similar reports on portal vein stenting have been reported to date. In this case, post-portal vein stenting angiography showed the contrast agent exhibiting unusual behavior (Figure 3d). Ordinarily, retrograde contrast flow into the distal SMV is not observed because of normal intestinal perfusion. It is hypothesized that compressive occlusion of the SMA by the stent leads to a marked reduction in arterial blood flow to the intestines, resulting in the absence of perfusion into the drainage veins of the intestines. SMA gas is a rare imaging finding often linked to severe intestinal ischemia and high mortality. D'Agostino et al. [9] reported a similar case, emphasizing its role as a sign of irreversible ischemia. Recognizing SMA gas is essential for timely diagnosis and intervention. No published reports support detection by point-of-care ultrasound alone. Therefore, contrast-enhanced CT remains necessary for accurate diagnosis and early treatment. The following factors are presumed to have contributed to the arterial occlusion. First, arterial stenosis owing to tumor infiltration is a potential cause. Given that the primary disease was pancreatic cancer, which has a strong propensity for invasion, severe arterial stenosis was already noted on preoperative CT. Second, the parallel course of the SMA and the occluded SMV were other factors. In addition, tumor-induced fixation of the artery and vein may have exacerbated arterial occlusion. Under normal circumstances, mesenteric vessels exist within a relatively free space, and the placement of a stent in a nearby vessel typically does not pose a problem. However, when the arteries and veins course together within the same tumor, their mobility is restricted, making them susceptible to stenosis or occlusion owing to compressive forces from the stent. Furthermore, in this case, the diameter of the portal vein stent is also considered a contributing factor to the occlusion. If the improvement in symptoms was due to increased blood flow, a smaller-diameter stent might have been sufficient. In this case, radiation therapy was administered to the tumor. Reports exist on arterial stenosis caused by radiation therapy, which is a contributing factor [10]. Elsayed et al. [11] reported a case in which a covered stent was placed for external iliac vein stenosis caused by a malignant tumor, resulting in severe stenosis of the adjacent external iliac artery immediately after the procedure. Risk factors for arterial ischemia include malignant tumors, a history of radiation therapy, previous surgery, and inflammation. It has been suggested that these factors may reduce the flexibility of the surrounding soft tissue and increase the compressive force exerted by the adjacent venous stent [11]. These factors align with those observed in our case, and we consider them to be important risk factors. To prevent and anticipate these complications, securing and effectively utilizing arterial routes is crucial. The preoperative evaluation of portal vein stenting requires a comprehensive understanding of the overall anatomy using contrast-enhanced CT, which is important. However, CT is insufficient for assessing the dynamic blood flow in the stenotic region. SMA portography provides more valuable information regarding the stenotic site, venous branches distal to the stenosis, collateral pathways, and the presence of thrombosis [12, 13]. SMA portography allows for the simultaneous evaluation of both portal and arterial blood flows. Hence, it is beneficial to perform contrast imaging via the SMA as a staged or single-step procedure. The single-step approach also enables assessing blood flow after portal vein stenting and evaluating whether the stent is functioning properly. Additionally, if portal pressure had been measured after stent placement, it might have been possible to evaluate changes in portal blood flow and detect arterial occlusion at an earlier stage. When arteries and veins course together within the same tumor, as seen in this case, and SMA stenosis is suspected, arterial occlusion caused by compression from a portal vein stent should be considered in the treatment strategy. If the utility of portal vein stenting is deemed high, we propose the following methods to prevent exacerbation or occlusion of arterial stenosis. In symptomatic cases following SMV or portal vein stenting, SMA stenting should be considered if anatomically feasible. If the stenosis is confined to the SMA trunk, stenting may be a viable option. However, in this case, due to severe stenosis involving multiple SMA branches, stenting was deemed impractical because of the risk of vascular injury and distal embolization. When stenting is not feasible, avoiding venous stent overexpansion becomes critical. Careful preprocedural planning, including detailed imaging and pressure gradient assessment, is essential. If SMA stenosis is suspected but mild, placing a safety wire during the procedure can preserve access and allow prompt intervention. This low-risk, cost-effective approach may be useful in anatomically complex cases. While transient abdominal pain may occur with reperfusion, high-risk patients require careful monitoring. Ultrasound may be used for initial screening, but it is not reliable for detecting mesenteric gas or early necrosis. In symptomatic high-risk cases, contrast-enhanced CT should be performed within hours. In our case, CT was delayed by about 9 hours, possibly contributing to bowel necrosis. When intestinal ischemia is suspected, urgent surgical exploration should not be delayed in improving outcomes. Conclusion In conclusion, this case highlights the risk of fatal intestinal ischemia after portal vein stenting, especially when the SMA and vein are fixed within the tumor. Limited vessel mobility and stent diameter may contribute to arterial compression. Preprocedural assessment of SMA patency, avoidance of overexpansion, and early imaging for abdominal symptoms are critical to prevent complications. Moreover, awareness of prior treatment history, such as radiation or surgery, should guide procedural planning and postoperative care. Author Contributions All authors read and approved the final manuscript. Conflicts of Interest There are no conflicts of interest. Informed Consent Upon admission, we obtained the patient's consent for the research use of test data and imaging data. However, we did not obtain consent again after the procedure. This case report was approved by the Institutional Review Board of our institution (approval number 20240174) in accordance with institutional policies for case report publication. References